Results 211 to 220 of about 56,166 (223)

Gastroenteropancreatic Neuroendocrine Tumors

Ca-A Cancer Journal for Clinicians, 2018
Mauro Cives
exaly  

Metabotropic glutamate receptor 1 blockade impairs acquisition and retention in a spatial Water maze task

Behavioural Brain Research, 2005
T. Steckler, A. M. Oliveira, C. V. Dyck, H. V. Craenendonck, Ana M.A. Mateus, X. Langlois, A. Lesage, J. Prickaerts   +7 more
semanticscholar   +1 more source

Pharmacological Characterization of a New, Orally Active and Potent Allosteric Metabotropic Glutamate Receptor 1 Antagonist, 4-[1-(2-Fluoropyridin-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]-N-isopropyl-N-methyl-3,6-dihydropyridine-1(2H)-carboxamide (FTIDC)

Journal of Pharmacology and Experimental Therapeutics, 2007
G. Suzuki, Toshifumi Kimura, A. Satow, N. Kaneko, Junko Fukuda, H. Hikichi, Naoko Sakai, S. Maehara, Hiroko Kawagoe-Takaki, Mikiko Hata, T. Azuma, S. Ito, H. Kawamoto, H. Ohta   +13 more
semanticscholar   +1 more source

Lung cancer: New biological insights and recent therapeutic advances

Ca-A Cancer Journal for Clinicians, 2011
Suresh S Ramalingam, Fadlo R Khuri
exaly  

Unique Antipsychotic Activities of the Selective Metabotropic Glutamate Receptor 1 Allosteric Antagonist 2-Cyclopropyl-5-[1-(2-fluoro-3-pyridinyl)-5-methyl-1H-1,2,3-triazol-4-yl]-2,3-dihydro-1H-isoindol-1-one

Journal of Pharmacology and Experimental Therapeutics, 2009
A. Satow, G. Suzuki, S. Maehara, H. Hikichi, T. Murai, T. Murai, Hiroko Kawagoe-Takaki, Mikiko Hata, S. Ito, S. Ozaki, H. Kawamoto, H. Ohta   +11 more
semanticscholar   +1 more source

Recent progress in the understanding, diagnosis, and treatment of gastroenteropancreatic neuroendocrine tumors

Ca-A Cancer Journal for Clinicians, 2011
Kiran K Turaga
exaly  

Pharmacological Effects of the Metabotropic Glutamate Receptor 1 Antagonist Compared with Those of the Metabotropic Glutamate Receptor 5 Antagonist and Metabotropic Glutamate Receptor 2/3 Agonist in Rodents: Detailed Investigations with a Selective Allosteric Metabotropic Glutamate Receptor 1 Antago

Journal of Pharmacology and Experimental Therapeutics, 2008
A. Satow, S. Maehara, S. Ise, H. Hikichi, Miyuki Fukushima, G. Suzuki, Toshifumi Kimura, Takeshi Tanaka, S. Ito, H. Kawamoto, H. Ohta   +10 more
semanticscholar   +1 more source

Changes in the carboxyl-terminal domain of metabotropic glutamate receptor 1 by alternative splicing generate receptors with differing agonist-independent activity.

Molecular Pharmacology, 1996
L. Prézeau, Jesus Gomeza, S. Ahern, Sophie Mary, T. Galvez, J. Bockaert, J. Pin   +6 more
semanticscholar   +1 more source

Advances in Prostate Cancer Chemotherapy: A New Era Begins

Ca-A Cancer Journal for Clinicians, 2005
Kenneth J Pienta, David C Smith
exaly  

Breast cancer statistics, 2013

Ca-A Cancer Journal for Clinicians, 2014
exaly